118
Participants
Start Date
May 31, 2023
Primary Completion Date
January 31, 2024
Study Completion Date
January 31, 2024
UZ Leuven, Leuven
MU Graz, Graz
University Clinical Center of Serbia, Belgrade
Clinical Center of Vojvodina, Novi Sad
Chaim Sheba Medical Center, Ramat Gan
Rambam Health Care Campus, Haifa
Hamilton Health Sciences Corporation, Hamilton
McGill University Health Centre, Montreal
Attikon General University Hospital, Athens
George Papanikolau, Thessaloniki
Institute of Hematology and Transfusion Medicine (IHTM), Warsaw
Lead Sponsor
Takeda
INDUSTRY